Výsledky vyhledávání

Comparison of the Ivermectin and Lopinavir/Ritonavir Treatment Outcomes among COVID-19 Mild to Moderate Cases in Kaduna State

Autor: Oyefabi A, Shuaibu Musa, Kambai H, Usman I, Gwamna J, Sheyin J, Ige O, Abdullahi M, Sunday J, Hn, Kera, Atiku A, Dauda H, Gc, Umeh, Olasinde T, Abdullahi A

Publikováno v: Europe PubMed Central

Ivermectin has been a popular anti-parasitic drug since the late 1970s. The promising result of in-vitro studies on the antiviral activity of the drug has led clinicians in many countries to use this drug to treat COVID-19 patients. This study determ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::161dc0449a1a6160da12968a085b248d
https://pubmed.ncbi.nlm.nih.gov/35278050

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání